Compare
Innovation Beverage Group Ltd vs Cirtran Corp vs MDWerks, Inc. vs Arcadia Biosciences, Inc.
| Latest fiscal year | Innovation Beverage Group Ltd IBG | Cirtran Corp CIRX | MDWerks, Inc. MDWK | Arcadia Biosciences, Inc. RKDA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.77M | $3.13M | $2.21M | $4.86M |
| Revenue growth (YoY) | -5.1% | +141.1% | -6.3% | -3.7% |
| Gross margin | 44.2% | 49.3% | -15.8% | 36.2% (computed) |
| Operating margin | -194.2% | -4.1% | -168.7% | -51.5% |
| Net margin | -223.4% | -22.4% | -171.5% | -48.1% |
| Net income | -$6.19M | -$701.6K | -$3.80M | -$2.34M |
| EPS (Diluted) | -$13.09 | -$0.14 | -$0.02 | -$1.71 |
| Operating cash flow | -$1.56M | -$1.34M | -$1.57M | -$4.74M |
| Free cash flow | -$1.57M | n/a | -$2.45M | -$4.74M |
| Cash & equivalents | $127.8K | n/a | n/a | $259.0K |
| Total assets | $1.29M | $2.51M | $4.05M | $6.55M |
| Total liabilities | $2.76M | $27.62M | $3.05M | $2.41M |
| Shareholders' equity | -$1.47M | -$25.11M | $1.00M | $4.14M |
| Return on year-end equity | n/a | n/a | -378.9% | -56.5% |
| Shares outstanding | 347.0K | 4.95M | 234.11M | 1.37M |
Revenue, most recent five fiscal years
| Fiscal year | Innovation Beverage Group Ltd | Cirtran Corp | MDWerks, Inc. | Arcadia Biosciences, Inc. |
|---|---|---|---|---|
| Latest | $2.77M Ended 2025-12-31 | $3.13M Ended 2025-12-31 | $2.21M Ended 2025-12-31 | $4.86M Ended 2025-12-31 |
| 1 year earlier | $2.92M Ended 2024-12-31 | $1.30M Ended 2024-12-31 | $2.36M Ended 2024-12-31 | $5.04M Ended 2024-12-31 |
| 2 years earlier | $3.15M Ended 2023-12-31 | $1.62M Ended 2023-12-31 | $104.1K Ended 2023-12-31 | $4.45M Ended 2023-12-31 |
| 3 years earlier | n/a | $1.72M Ended 2022-12-31 | n/a | $7.42M Ended 2022-12-31 |
| 4 years earlier | n/a | $2.92M Ended 2021-12-31 | n/a | $6.78M Ended 2021-12-31 |